Premium Nahrungsergänzungsmittel | artgerecht

Trimethylamine N Oxide (TMAO) – Meaning & Heart Risk

Trimethylamine N Oxide (TMAO) is a metabolite produced in the gut from dietary nutrients and has been linked to an increased risk of cardiovascular disease.

Regular tips about health Regular tips about health

Things worth knowing about "Trimethylamine N Oxide"

Trimethylamine N Oxide (TMAO) is a metabolite produced in the gut from dietary nutrients and has been linked to an increased risk of cardiovascular disease.

What is Trimethylamine N Oxide?

Trimethylamine N Oxide (TMAO) is an organic compound produced through a multi-step metabolic process. Dietary nutrients – primarily choline, lecithin, and L-carnitine – are first converted by gut bacteria into trimethylamine (TMA). TMA is then transported to the liver, where the enzyme flavin monooxygenase 3 (FMO3) oxidizes it into TMAO. TMAO then circulates in the bloodstream and is excreted through the kidneys.

Biological Background and Mechanism of Action

The production of TMAO is strongly influenced by the composition of the gut microbiome. Individuals with different gut bacterial populations can produce vastly different amounts of TMAO from the same dietary intake. Foods rich in choline and L-carnitine – such as red meat, eggs, organ meats, and seafood – are the primary drivers of TMAO production.

TMAO interferes with cholesterol and bile acid metabolism, promoting the deposition of cholesterol in arterial walls. It has also been associated with increased platelet reactivity, which may elevate the risk of blood clot formation.

TMAO and Cardiovascular Disease

Several landmark studies, particularly from the Cleveland Clinic, have demonstrated that elevated TMAO blood levels are associated with an increased risk of:

Atherosclerosis (hardening and narrowing of the arteries)
Heart attack (myocardial infarction)
Stroke
Heart failure

TMAO is therefore considered a potential biomarker – a measurable substance in the blood that can indicate elevated cardiovascular risk, independent of traditional risk factors such as cholesterol or blood pressure.

Factors Influencing TMAO Levels

Diet

Diets high in animal products – particularly red meat, eggs, and seafood – tend to increase TMAO production. A plant-based diet is generally associated with lower TMAO levels, as plants contain less choline and virtually no L-carnitine, and individuals following plant-based diets tend to harbor gut microbiomes less capable of producing TMA.

Gut Microbiome

The individual composition of the gut flora is a key determinant of TMAO production. People with microbiomes dominated by TMA-producing bacteria generate significantly more TMAO from the same dietary sources compared to individuals with plant-adapted microbiomes.

Kidney Function

Since TMAO is excreted by the kidneys, individuals with impaired kidney function may accumulate higher plasma TMAO concentrations, further increasing their cardiovascular risk.

Diagnosis and Measurement

TMAO can be measured in blood plasma or urine, typically using mass spectrometry. While TMAO testing is not yet part of routine clinical diagnostics, it is used in research settings and specialized cardiovascular risk assessment. Elevated TMAO is considered an independent predictor of adverse cardiovascular outcomes.

Strategies to Reduce TMAO Levels

The following approaches may help lower TMAO blood levels:

Plant-based diet: Reducing intake of red meat, eggs, and high-choline animal foods can significantly lower TMAO production.
Probiotics and dietary fiber: Supporting a healthy and diverse gut microbiome may reduce TMA-producing bacterial populations.
3,3-Dimethyl-1-Butanol (DMB) and resveratrol: Certain plant-derived compounds are being investigated as potential inhibitors of microbial TMA production.
Regular physical activity: Exercise has been shown to positively influence the gut microbiome composition and may help reduce TMAO levels.

References

Wang, Z. et al. (2011): Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature, 472, 57–63. DOI: 10.1038/nature09922
Tang, W. H. W. et al. (2013): Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. New England Journal of Medicine, 368, 1575–1584. DOI: 10.1056/NEJMoa1109400
Zhu, W. et al. (2016): Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk. Cell, 165(1), 111–124. DOI: 10.1016/j.cell.2016.02.011

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.